Skip to main content

Table 2 Effect of labetalol infusion on cardiovascular parameters, reported as mean (± SD)

From: Retrospective evaluation of labetalol as antihypertensive agent in dogs

 

T0

T1

T2

T3

T4

SAP

175 (±25)

p = 0.0019

152 (±38)

p = 0.0041

150 (±28)

p = 0.0079

144 (±28)

p = 0.0009

142 (±30)

p = 0.0002

MAP

130 (±22)

p = 0.0001

113 (±28)

p = 0.0519

108 (±20)

p = 0.0048

101 (±19)

p = 0.0004

98 (±20)

p < 0.0001

DAP

108 (±20)

p < 0.0001

90 (±25)

p = 0.0263

85 (±16)

p = 0.0017

80 (±14)

p < 0.0001

77 (±17)

p < 0.0001

HR

95 (±35)

p = 0.2454

88 (±20)

93 (±28)

95 (±22)

98 (±24)

  1. Thep value in the first column indicates the overall ANOVA p value, while the p values reported under the other columns indicate the post hoc p values in comparison with T0. SAP Systolic arterial pressure, MAP Mean arterial pressure, DAP Diastolic arterial pressure, HR Heart rate, T0 Beginning of the labetalol infusion; T1, T2, T3, T4: 15, 30, 45 and 60 min after the start of the infusion, respectively